Post-Market Clinical Follow-Up Study Plan for Cartridges of Disposable Endoscopic Linear Cutting Staplers

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSuzhou Care-Real Medical Technology Co., Ltd.

About this trial

Cartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable Powered Endoscopic Linear Cutting Staplers and Disposable Endoscopic Linear Cutting Staplers manufactured by Ningbo Verykind Medical Device Co., Ltd. have marketed in many countries or area for many years. The investigational devices are intended for transection, resection, and/or creation of anastomoses. The instruments have application in multiple open or minimally invasive general, gynecologic, urologic and thoracic surgical procedures.

In order to confirm the safety and performance of the products, as well as the continued safety and clinical performance of the implant (the staple) during the clinical follow-up period, monitor the identified side-effects, contraindications and identify previously unknown side-effects, and ensure the continued acceptability of the benefit-risk ratio, Investigators proactively collect and evaluate clinical data from different regions, including of Italy, Brazil and Chile, where the device has been marketed, and conduct PMCF studies.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age≥18 years old, gender unlimited;

The surgery type shall be open or endoscopic surgery;

The departments of surgical procedures: general, gynecologic, urologic and thoracic surgical procedures;

Investigational devices listed in this PMCF plan must be used during surgical procedures.

Disqualifiers

Patients with surgical contraindications to the product, e.g. use the instruments on large arteries, on ischemic or necrotic tissue, use the device on tissues with a compression thickness out of the device range;

Concomitant with similar devices (staplers/reloads/cartridges, etc.) for resection, transection and anastomosis of surgical organ or tissues;

The operation record is incomplete, and the information related to the main indicators cannot be extracted.

Trial population

Cartridges of Disposable Endoscopic Linear Cutting Staplers are intended for transection, resection, and/or creation of anastomoses. The instruments are applied in multiple open or minimally invasive general, gynecologic, urologic and thoracic surgical procedures. They must be used in combination with Disposable Powered Endoscopic Linear Cutting Staplers or Disposable Endoscopic Linear Cutting Staplers manufactured by the Company.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Cartridges of Disposable Endoscopic Linear Cutting Staplers, Disposable Powered

    Device

    Investigational devices encompassing all models of the Cartridges for Disposable Endoscopic Linear Cutting Staplers, as well as Staplers utilized in conjunction with the Cartridges specified in the Study Plan (Plan number: WEKD-QS-PMCF).

Treatment groups

300 Participants
are divided into 1 treatment group
Group A: Cartridges of Disposable Endoscopic Linear Cutting Staplers1 intervention

Trial outcomes

Primary outcomes

1

Anastomosis success rate

According to surgical records and inpatient medical records, no reoperation in situ is defined as successful anastomosis.

Time frame
The investigation sites will be collected from January 2023 to June 2024.

Secondary outcomes

1

Anastomotic bleeding rate

Time frame
The incidence of anastomotic bleeding during day of operation and 6 months after operation was recorded.
2

Anastomotic leakage rate

Time frame
The incidence of leakage during day of operation and 6 months after operation was recorded.
3

Anastomotic stenosis rate

Time frame
The incidence of anastomotic stenosis during day of operation and 6 months after operation was recorded.

Other outcomes

1

Surgical time

Time frame
The investigation sites will be collected from January 2023 to June 2024.
2

Intraoperative bleeding

Time frame
The investigation sites will be collected from January 2023 to June 2024.
3

Intraoperative conversion (due to device reasons)

Time frame
The investigation sites will be collected from January 2023 to June 2024.
4

Length of hospitalization

Time frame
The investigation sites will be collected from January 2023 to June 2024.

Locations

1

Map coordinates are unavailable for these locations. Locations are shown below instead.

Cartridges of Disposable Endoscopic Linear Cutting StaplersRecruiting315101, Ningbo, ZhejiangChileChile

Sponsors and contacts

Click on the lead sponsor to view all of their trials.